Skip to content
Yog Pharma
GastrointestinalProton pump inhibitor

Pantoprazole Sodium is a proton pump inhibitor indicated for erosive esophagitis associated with GERD and Zollinger-Ellison syndrome. We supply it to US manufacturers of delayed-release tablets, delayed-release oral suspension and injection.

CAS164579-32-2432.4 g/molC16H14F2N3NaO4S1.5H2O
2D structure of Pantoprazole Sodium, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 67047490) and FDA’s substance registry

CAS number

164579-32-2

Molecular formula

C16H14F2N3NaO4S1.5H2O

Molecular weight

432.4g/mol

FDA UNII

IUPAC name

sodium 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide sesquihydrate

InChIKey

RJRBTVMZZGMTQI-UHFFFAOYSA-N

Appearance
White to off-white crystalline powder.
Solubility
Freely soluble in water, very slightly soluble in phosphate buffer at pH 7.4, and practically insoluble in n-hexane.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Supplied as the sesquihydrate. Injection-grade material has tighter limits than oral grade, so say which dosage form you make.

On the US market

Reference product
ProtonixNDA 020987
Approved ANDAs
31 with a marketed product
Approved forms and strengths
  • Delayed-release tablet 20 mg, 40 mg
  • Injection 40 mg per vial, 40 mg/100 mL, 40 mg/50 mL, 80 mg/100 mL
  • Delayed-release granules for oral suspension 40 mg
  • Powder for injection 40 mg per vial

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com